Urgent high quality communications from across the chemical sciences.
Impact Factor 6.718 100 Issues per Year Indexed in MEDLINE
Communication

Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Institute of Cancer Therapeutics, University of Bradford, West Yorkshire BD7 1DP, UK
E-mail: L.H.Patterson@Bradford.ac.uk
b
Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, London, UK
c
School of Pharmacy, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK
Chem. Commun., 2011,47, 12062-12064

DOI: 10.1039/C1CC15638A
Received 12 Sep 2011, Accepted 04 Oct 2011
First published online 14 Oct 2011
| | | | | | More
Please wait while Download options loads
Download Citation
 
 

Supplementary Info